Uptrend Call Working As BioCryst Pharmaceuticals Stock Rises 30.9% (BCRX)
March 16, 2017 at 02:20 AM EDT
SmarTrend identified an Uptrend for BioCryst Pharmaceuticals (NASDAQ:BCRX) on March 1st, 2017 at $6.68. In approximately 2 weeks, BioCryst Pharmaceuticals has returned 30.94% as of today's recent price of...
